1-3 of 3
Catherine Bagot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy

CME Clinical Trials & Observations
Andrew J. Doyle, Matthew J. Stubbs, Tina Dutt, Will Lester, Will Thomas, Joost van Veen, Joannes Hermans, Tanya Cranfield, Quentin A. Hill, Amanda Clark, Catherine Bagot, Steven Austin, John-Paul Westwood, Mari Thomas, Marie Scully
Journal: Blood
Blood (2023) 141 (3): 285–294.
https://doi.org/10.1182/blood.2022017023
Published: 2023
Journal Articles

A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate. the Flight Trial

Charlotte A Bradbury, MD MSc, FRCP, FRCPath, PhD, Rosemary Greenwood, Julie Pell, Katie Breheny, Rebecca Kandiyali, Jenny Ingram, Ian Thomas, Catherine Bagot, MD FRCPath, MBBS, Quentin Hill, HaemSTAR Collaborators, Nichola Cooper
Journal: Blood
Blood (2020) 136 (Supplement_2): LBA-2.
https://doi.org/10.1182/blood-2020-143563
Published: 2020
Journal Articles

Real World Use of Thrombopoietin-Receptor Agonists in the Management of Immune Thrombocytopenia in the United Kingdom: Results from the TRAIT Study

Nichola Cooper, MRCP, Andrew Provan, Marie Scully, MD MRCP, FRCPath, Henri Grech, Catherine Bagot, MD FRCPath, MBBS, Quentin A Hill, BSc, MBChB, MRCP, FRCPath, Tim Nokes, Nicholas Ramscar, Luke Saunders
Journal: Blood
Blood (2018) 132 (Supplement 1): 2426.
https://doi.org/10.1182/blood-2018-99-110126
Published: 2018